SK Chemicals acquires commercialization approval of world’s 2nd zoster vaccine ‘Sky Zoster’

Published: 2017-10-11 16:30:00
Updated: 2017-10-11 14:27:50

A Korean pharmaceutical company is expected to widen options for patients using its excellent technology power in the world’s zoster vaccine market which has been monopolized by a global pharmaceutical company.

SK Chemicals announced on the 9th that ‘Sky Zoster Inj(project name: NBP608),’ the co...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.